EGFR/CSC-IN-1 is a potent inhibitor of the epidermal growth factor receptor (EGFR) with an IC50 of 10.52 nM, and it also targets cancer stem cells (CSCs). This dual inhibition is particularly relevant for research focused on triple-negative breast cancer, offering a pathway to explore therapeutic strategies that may improve treatment outcomes in this aggressive malignancy.
EGFR/CSC-IN-1 is a potent inhibitor of the epidermal growth factor receptor (EGFR) with an IC50 of 10.52 nM, and it also targets cancer stem cells (CSCs). This dual inhibition is particularly relevant for research focused on triple-negative breast cancer, offering a pathway to explore therapeutic strategies that may improve treatment outcomes in this aggressive malignancy.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
